hemophilia B


Also found in: Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.
Related to hemophilia B: Hemophilia C, Von Willebrand disease
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.hemophilia B - a clotting disorder similar to hemophilia A but caused by a congenital deficiency of factor IX
bleeder's disease, haemophilia, hemophilia - congenital tendency to uncontrolled bleeding; usually affects males and is transmitted from mother to son
References in periodicals archive ?
Hemophilia B is a chronic and inherited bleeding disorder that affects approximately 5,000 people in the U.
Visit Hemophilia Treatment Market by Drug Type (Antifibrinolytic Agents, Desmopressin, Plasma Derived Coagulation Factor Concentrates - Factor VIII, Factor IX, Combination, Recombinant Coagulation Factor Concentrates - Factor VIII, Factor IX, Combination), Indication Type (Acquired Hemophilia, Hemophilia A, Hemophilia B, Hemophilia C), and Distribution Channel (E-commerce, Hospital Pharmacies, Retail Pharmacies) and Forecast 2017-2021 at https://www.
In this case report, the difficulties in treatment of an infant with severe hemophilia B who developed antibody and allergic reaction against FIX treatment have been discussed.
The report provides a snapshot of the global therapeutic landscape of Hemophilia B
Early identification of canine hemophilia A, hemophilia B and von Willebrand disease (VWD), a severe bleeding defect.
53%) were hemophila A & hemophilia B respectively, and 6 (2.
As part of Wyeth's agreement with France-based Nautilus Biotech, the latter company will apply its proprietary technology to improve the action of recombinant hemophilia B therapy.
Relief from this inherited clotting disorder, hemophilia B, has now come a step closer, thanks to gene therapy performed on a unique group of hemophiliac dogs.
Depending on the critical clotting factor missing, the disorder is identified as Hemophilia A, Hemophilia B, Von Willebrand Disease, or another rarer condition.
The US will have the largest proportion of diagnosed prevalent cases of hemophilia A and hemophilia B in the 9MM in 2024 at 29.
This week, a scientific team reports using gene therapy to treat dogs with a canine version of hemophilia B, an inherited bleeding disease that afflicts one of every 30,000 persons.